OR WAIT null SECS
Pharmaceutical product distributor continues goal of delivering safe and affordable medication to patients.
Milla Pharmaceutical Inc., a subsidiary of the Alter Pharma Group, is now becoming an A.forall company. With that, The Alter Pharma Group, a group of generic and pharmacy sales companies, is rebranding all its brands and businesses into A.forall. This change is on brand with A. forall’s objective or providing patients access to high-quality, safe and medicines at an affordable price.
Alter Pharma started pharmacy sales in 2006. In 2010, it became the Alter Pharma Group after the consolidation of several entities and last year, the group made its first major acquisition. Its generics business currently markets more than 30 in-house developed added value products that are being sold in more than 60 countries around the globe including US, whereas A.forall’s Benelux Pharmacy House provides medicine shortage services through hospital and retail pharmacies.
“The Alter Pharma Group has been going through a period of incredible evolution and innovation over the past years. We could not be more excited about the next step: our rebranding to A.forall,” saysFilip Van de Vliet, Alter Pharma Group’s CEO. “We’re coming together better and stronger than ever in order to deliver on our mission of making affordable medicines available to all.”